Cargando…
Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double‐blind placebo‐controlled trial
Aims/Introduction: Diabetic peripheral neuropathy (DPN) is often associated with pain, and thus a new treatment option is anticipated. We recently showed the efficacy of pregabalin in a randomized, double‐blind, placebo‐controlled, 14‐week trial in Japanese patients with painful DPN. In the present...
Autores principales: | Satoh, Jo, Yagihashi, Soroku, Baba, Masayuki, Suzuki, Makoto, Arakawa, Akio, Yoshiyama, Tamotsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014905/ https://www.ncbi.nlm.nih.gov/pubmed/24843530 http://dx.doi.org/10.1111/j.2040-1124.2011.00122.x |
Ejemplares similares
-
The efficacy of pregabalin for the treatment of neuropathic pain in Japanese subjects with moderate or severe baseline pain
por: Parsons, Bruce, et al.
Publicado: (2019) -
An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain
por: Onouchi, Kenji, et al.
Publicado: (2014) -
The Possible Role of Tumor Necrosis Factor-α in Diabetic Polyneuropathy
por: Satoh, Jo, et al.
Publicado: (2003) -
The Impact of Low-Dose Insulin on Peripheral Nerve Insulin Receptor Signaling in Streptozotocin-Induced Diabetic Rats
por: Sugimoto, Kazuhiro, et al.
Publicado: (2013) -
Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial
por: Markman, John, et al.
Publicado: (2018)